Study of Microcirculation During Extracorporeal Circulation in Cardiac Surgery

Sponsor
AHEPA University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04058860
Collaborator
Medtronic - MITG (Industry)
30
1
1
18
1.7

Study Details

Study Description

Brief Summary

The aim of the proposed study is to evaluate microcirculatory alterations in patients undergoing open heart surgery under extracorporeal circulation. Positive clinical results evidenced with goal-directed perfusion and cerebral oximetry monitoring could be attributed to preserved microcirculation at tissue level.

Condition or Disease Intervention/Treatment Phase
  • Device: NIRS monitoring
  • Device: Cox monitoring
  • Device: Sublingual microscopy
N/A

Detailed Description

The aim of the proposed study is to evaluate microcirculatory alterations in patients undergoing open heart surgery under extracorporeal circulation. Microcirculatory changes during cardiac surgery have been investigated mainly during coronary procedures using the conventional extracorporeal circulation. There is no single study in the literature investigating microcirculatory alterations using a perioperative strategy of "physiologic" perfusion. Positive clinical results evidenced with goal-directed perfusion and cerebral oximetry monitoring could be attributed to preserved microcirculation at tissue level.

All patients will follow the same anaesthetic and perfusion protocol. The protocol for the evaluation of microcirculation will be based on:

  • Cerebral near-infrared spectroscopy (rScO2) measurements (INVOS, Covidien-Medtronic Inc.).

  • NIRS-Based Cerebral Autoregulation Monitoring: Analog arterial blood pressure signals will be digitized and then processed with the digital NIRS signals using a personal computer and a special ICM software (University of Cambridge, Cambridge, UK). Monitoring cerebral autoregulation ensures adequate renal perfusion. Hence, brain can be used not just as a target but also as an index organ indicating adequacy of perfusion.

  • Somatic near-infrared spectroscopy (rSsO2) measurements (INVOS, Covidien-Medtronic Inc.).

  • Sublingual mucosal microcirculation measurements during surgery using side dark field (SDF) imaging (MicroScan, Microvision Medical, Amsterdam, The Netherlands).

All measurements will be performed at the following time points:

T0: after induction of anaesthesia T1: after initiation of cardiopulmonary bypass T2: 10 minutes after cross- clamping the aorta T3: 10 minutes before removing the aortic cross-clamp T4: after weaning from extracorporeal circulation

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Patients undergoing open heart surgery with minimal invasive extracorporeal circulation (MiECC) according to accepted indicationsPatients undergoing open heart surgery with minimal invasive extracorporeal circulation (MiECC) according to accepted indications
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Study of Microcirculation During Extracorporeal Circulation in Cardiac Surgery; Challenging Near-infrared Spectroscopy With Microvascular Density and Metabolic Parameters
Actual Study Start Date :
Jun 1, 2020
Actual Primary Completion Date :
Nov 30, 2021
Actual Study Completion Date :
Nov 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Other: Study Patients

Patients undergoing open heart surgery with minimal invasive extracorporeal circulation (MiECC) according to accepted indications

Device: NIRS monitoring
Cerebral and somatic near-infrared spectroscopy (rScO2) measurements

Device: Cox monitoring
Cerebral autoregulation monitoring

Device: Sublingual microscopy
Sublingual mucosal microcirculation measurements during surgery using side dark field (SDF) imaging

Outcome Measures

Primary Outcome Measures

  1. Evaluation of microcirculation [During surgery, from induction of anesthesia to weaning of extracorporeal circulation]

    Correlation of NIRS values with tissue microvascular activity

Secondary Outcome Measures

  1. Global perfusion [During surgery, from induction of anesthesia to weaning of extracorporeal circulation]

    Global perfusion using cerebral NIRS during extracorporeal circulation

  2. Cerebral autoregulation [During surgery, from induction of anesthesia to weaning of extracorporeal circulation]

    Calculation of cerebral oximetry index (COx)

  3. Goal-directed perfusion [During surgery, from induction of anesthesia to weaning of extracorporeal circulation]

    Correlation of goal-directed perfusion with microvascular capillary density during extracorporeal circulation

  4. Somatic perfusion [During surgery, from induction of anesthesia to weaning of extracorporeal circulation]

    Peripheral tissue oxygenation as measured with somatic NIRS

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients aged > 18 and < 85 years with coronary artery disease and/or aortic valve disease undergoing open heart surgery with accepted indications
Exclusion Criteria:
  • patients undergoing emergency surgery

  • patients in preoperative cardiogenic shock with evidence of tissue malperfusion

  • patients > 85 years of age

  • patients with severe peripheral vascular disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cardiothoracic Department, AHEPA University Hospital Thessaloniki Greece

Sponsors and Collaborators

  • AHEPA University Hospital
  • Medtronic - MITG

Investigators

  • Principal Investigator: Kyriakos Anastasiadis, MD, PhD, Cardiothoracic Department, AHEPA University Hospital, Thessaloniki, Greece
  • Principal Investigator: Helena Argiriadou, MD, PhD, Cardiothoracic Department, AHEPA University Hospital, Thessaloniki, Greece

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Kyriakos Anastasiadis, Professor of Cardiac Surgery, AHEPA University Hospital
ClinicalTrials.gov Identifier:
NCT04058860
Other Study ID Numbers:
  • AHEPA_CTS
First Posted:
Aug 16, 2019
Last Update Posted:
Jul 25, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kyriakos Anastasiadis, Professor of Cardiac Surgery, AHEPA University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 25, 2022